{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:16:33Z","timestamp":1780391793378,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05068-z","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:21:10Z","timestamp":1776698470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A case of breast acinar cell carcinoma combined with metaplastic carcinoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Sichun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaiyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"5068_CR1","doi-asserted-by":"publisher","first-page":"1438179","DOI":"10.3389\/fonc.2024.1438179","volume":"14","author":"Y Ge","year":"2024","unstructured":"Ge Y, Wei X, Liu JN, Sun PL, Gao H. New insights into acinic cell carcinoma of the breast: clinicopathology, origin of histology, molecular features, prognosis, and treatment. Front Oncol. 2024;14:1438179.","journal-title":"Front Oncol"},{"issue":"5","key":"5068_CR2","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/PAS.0000000000002363","volume":"49","author":"F Qin","year":"2025","unstructured":"Qin F, Li J, Zheng Y, Jiang C, Jia Y, Sun H, Xue H. Breast Carcinomas Resembling Acinic Cell Carcinoma: Comprehensive Analysis of 14 Cases and Review of the Literature. Am J Surg Pathol. 2025;49(5):448\u201357.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"5068_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF00196823","volume":"429","author":"F Roncaroli","year":"1996","unstructured":"Roncaroli F, Lamovec J, Zidar A, Eusebi V. Acinic cell-like carcinoma of the breast. Virchows Arch. 1996;429(1):69\u201374.","journal-title":"Virchows Arch"},{"key":"5068_CR4","doi-asserted-by":"publisher","first-page":"102830","DOI":"10.1016\/j.ctrv.2024.102830","volume":"131","author":"Y Lu","year":"2024","unstructured":"Lu Y, Kong X, Wang X, Zhang W, Li Y, Dong H, Wang Z. Deciphering primary acinic cell carcinoma of the Breast: Insights from a comprehensive case series and Systematic review. Cancer Treat Rev. 2024;131:102830.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"5068_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13000-024-01521-1","volume":"19","author":"Y Ge","year":"2024","unstructured":"Ge Y, Wei X, Liu JN, Sun PL, Gao H. Elucidating the nature of acinic cell carcinoma of the breast with high-grade morphology: evidence from case report. Diagn Pathol. 2024;19(1):100.","journal-title":"Diagn Pathol"},{"issue":"10","key":"5068_CR6","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/modpathol.2017.57","volume":"30","author":"PP Rosen","year":"2017","unstructured":"Rosen PP. So-called acinic cell carcinoma of the breast arises from microgladular adenosis and is not a distinct entity. Mod Pathol. 2017;30(10):1504.","journal-title":"Mod Pathol"},{"issue":"3","key":"5068_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3892\/ol.2024.14241","volume":"27","author":"X Yang","year":"2024","unstructured":"Yang X, Liu F, Li C, Li Z, Wang P, Zhang M, Liu Y. Clinicopathological, immunohistochemical and molecular features of acinic cell carcinoma of the breast. Oncol Lett. 2024;27(3):107.","journal-title":"Oncol Lett"},{"issue":"2","key":"5068_CR8","first-page":"43","volume":"16","author":"L Sarsiat","year":"2022","unstructured":"Sarsiat L, Watkinson G, Turnbull A, Diana A, Oikonomidou O. Prim acinic cell carcinoma Oncol. 2022;16(2):43.","journal-title":"Prim acinic cell carcinoma Oncol"},{"issue":"1","key":"5068_CR9","first-page":"e51427","volume":"16","author":"ISS Atta","year":"2024","unstructured":"Atta ISS. Acinic Cell Carcinoma of the Breast: A Case Report and Review of Literature. Cureus. 2024;16(1):e51427.","journal-title":"Cureus"},{"issue":"1","key":"5068_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF02967419","volume":"5","author":"K Shimao","year":"1998","unstructured":"Shimao K, Haga S, Shimizu T, Imamura H, Watanabe O, Kinoshita J, Nagumo H. Acinic Cell Adenocarcinoma Arising in the Breast of a Young Male: A Clinicopathological, Immunohistochemical and Ultrastructural Study. Breast Cancer. 1998;5(1):77\u201381.","journal-title":"Breast Cancer"},{"key":"5068_CR11","doi-asserted-by":"crossref","unstructured":"Winkler N, Morrell G, Factor RE. Invasive carcinoma with acinic cell-like features of the breast. Breast J. 2013 May-Jun;19(3):334\u20135.","DOI":"10.1111\/tbj.12119"},{"issue":"4","key":"5068_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/his.12673","volume":"67","author":"S Piscuoglio","year":"2015","unstructured":"Piscuoglio S, Hodi Z, Katabi N, Guerini-Rocco E, Macedo GS, Ng CK, Edelweiss M. Are acinic cell carcinomas of the breast and salivary glands distinct diseases? Histopathology. 2015;67(4):529\u201337.","journal-title":"Histopathology"},{"issue":"2","key":"5068_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/path.4566","volume":"237","author":"E Guerini-Rocco","year":"2015","unstructured":"Guerini-Rocco E, Hodi Z, Piscuoglio S, Ng CK, Rakha EA, Schultheis AM, Marchi\u00f2 C. The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study. J Pathol. 2015;237(2):166\u201378.","journal-title":"J Pathol"},{"key":"5068_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.humpath.2015.12.014","volume":"51","author":"N Conlon","year":"2016","unstructured":"Conlon N, Sadri N, Corben AD, Tan LK. Acinic cell carcinoma of breast: morphologic and immunohistochemical review of a rare breast cancer subtype. Hum Pathol. 2016;51:16\u201324.","journal-title":"Hum Pathol"},{"issue":"1","key":"5068_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/pin.13302","volume":"73","author":"T Sugino","year":"2023","unstructured":"Sugino T, Kakuda Y, Yasui H, Oishi T, Norose T, Kawata T, Tadokoro Y. A case of extensively spreading acinic cell carcinoma of the breast with microglandular features. Pathol Int. 2023;73(1):45\u201351.","journal-title":"Pathol Int"},{"key":"5068_CR16","first-page":"736048","volume":"2013","author":"J Falleti","year":"2013","unstructured":"Falleti J, Coletti G, Rispoli E, Scarabeo F, Cervasio M, Tornillo L, Pettinato G. Acinic cell carcinoma of the breast arising in microglandular adenosis. Case Rep Pathol. 2013;2013:736048.","journal-title":"Case Rep Pathol"},{"issue":"6","key":"5068_CR17","doi-asserted-by":"publisher","first-page":"100144","DOI":"10.1016\/j.modpat.2023.100144","volume":"36","author":"ET Richardson","year":"2023","unstructured":"Richardson ET, Selenica P, Pareja F, Cin PD, Hanlon E, Weigelt B, Reis-Filho JS. NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift. Mod Pathol. 2023;36(6):100144.","journal-title":"Mod Pathol"},{"issue":"9","key":"5068_CR18","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1097\/PAS.0000000000001494","volume":"44","author":"F Haller","year":"2020","unstructured":"Haller F, Moskalev EA, Kuck S, Bieg M, Winkelmann C, M\u00fcller SK, Ihrler S. Nuclear NR4A2 (Nurr1) Immunostaining is a Novel Marker for Acinic Cell Carcinoma of the Salivary Glands Lacking the Classic NR4A3 (NOR-1) Upregulation. Am J Surg Pathol. 2020;44(9):1290\u20132.","journal-title":"Am J Surg Pathol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05068-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05068-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05068-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:44:25Z","timestamp":1780389865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05068-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5068"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05068-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Hefei Anweikang Medical Laboratory Pathology Center, confirming its compliance with the relevant guidelines of the International. Committee of Medical Journal Editors (ICMJE). The above content can be reflected in the patient\u2019s admission authorization form, and no further ethical approvals are required. All personal data have been processed in an anonymous form to protect patient privacy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained for the patient\u2019s data included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Written informed consent was obtained from the patients to participate in this work and to use their case details for teaching and publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"832"}}